Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
LINCOLN Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Moderate ROE but declining trend
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Moderate and stable operating margin
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
LINCOLN Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
LINCOLN Bulk, Block & Insider Trades
LINCOLN Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Stock split
Others
Stock split(1 : 5)Nominal value has changed from Rs 10 to Rs 2. Ex-date: 8th Feb 2006 Announced on: 31st Jan 2006
Stock consolidationNominal value change from Rs 2 to Rs 10. Ex-date: 19th Mar 2009 Announced on: 1st Oct 2008
Company Profile
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company’s product categories include tablets, capsules, liquid injection, crea... Read More
Key personnel
Mr. Kishor M. ShahD
Non-Executive Non-Independent Chairman of the Board
Mr. Darshit A. Shah
Chief Financial Officer
Ms. Trusha Kashish Shah
Compliance Officer, Company Secretary
Mr. Mahendrabhai Gulabdas PatelD
Managing Director, Executive Director
Mr. Ashish Rajanikant PatelD
Whole Time Director
Mr. Hasmukhbhai Ishwarlal PatelD
Whole Time Director
Mr. Munjal Mahendrabhai PatelD
Whole Time Director
Mr. Rajnikant Gulabdas PatelD
Non-Executive Non-Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Lincoln Pharmaceuticals Ltd.?
The current share price of Lincoln Pharmaceuticals Ltd. is ₹ 487.08 as of 09 Jan 2026.
What is the PE ratio of Lincoln Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Lincoln Pharmaceuticals Ltd. is 12.19 as of the latest financial data.
What is the ROE and ROCE of Lincoln Pharmaceuticals Ltd.?
Lincoln Pharmaceuticals Ltd. has a Return on Equity (ROE) of 11.81% and a Return on Capital Employed (ROCE) of 12.69% as per the latest financial reports.
What is the market cap of Lincoln Pharmaceuticals Ltd.?
The market capitalization of Lincoln Pharmaceuticals Ltd. stands at ₹ 975.62 Cr.
What is the dividend yield of Lincoln Pharmaceuticals Ltd.?
The dividend yield of Lincoln Pharmaceuticals Ltd. is 0.37% based on the current market price.
What is the RSI of Lincoln Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Lincoln Pharmaceuticals Ltd. is 48.79.
What is the FII and DII holding in Lincoln Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 4.73% and Domestic Institutional Investors (DII) hold 0.00% of Lincoln Pharmaceuticals Ltd. shares.
What sector does Lincoln Pharmaceuticals Ltd. belong to?
Lincoln Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Lincoln Pharmaceuticals Ltd. stock?
The beta of Lincoln Pharmaceuticals Ltd. stock is 1.07, indicating its volatility relative to the broader market.
